Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Convertible Loan Notes update

13 Jun 2017 07:00

RNS Number : 8750H
Kin Group PLC
13 June 2017
 

Kin Group Plc / Epic: KIN / Index: AIM

 

RNS ANNOUNCEMENT: The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

 

13 June 2017

 

KIN GROUP PLC ('KIN' OR 'THE COMPANY')

 

Convertible Loan Notes update

On 15 May 2017, Kin Group Plc (AIM: KIN), the AIM quoted digital wellness provider for corporate organisations trading as Kin Wellness, announced that it had agreed to issue convertible unsecured loan notes with a term of three years ("Notes"), to raise up to £1.125 million (before expenses) in four tranches, to Belastock Capital L.P., an overseas based institutional investor ("Belastock") to fund its general working capital requirements.

The issue of the Notes was subject to the terms and conditions summarised in the announcement dated 15 May. The first tranche of Notes with a nominal amount of £350,000 and a subscription price of £315,000 ("Tranche 1 Notes") were issued on 15 May 2017 with the remaining three tranches being issued at 60 day intervals thereafter.

One of the conditions attaching to the issue of subsequent Notes, which can be waived by Belastock, is that the closing bid price of the Company's ordinary shares (as reported by Bloomberg) falls below £0.001 (0.1 pence) for any five (5) consecutive trading days on or prior to the relevant issue date. The Company notes that this condition was not met at the close of business last night, 12 June 2017.

Notwithstanding this breach of the condition the Directors are pleased to report that Belastock has confirmed its ongoing support for the Company and that it is the current intention of Belastock to subscribe for the remaining tranches of the Notes as previously outlined. The second tranche of the Notes, which should raise approximately £255,000 (net of expenses), are due to be issued in mid-July.

Further announcements will be made as appropriate.

 

 

**ENDS**

 

For further information visit www.kinwellness.com

 

Contact:

 

Anna Gudmundson / Donald Stewart

 

Kin Group Plc

020 7449 4949

Mark Brady / Neil Baldwin

 

SPARK Advisory Partners Limited (Nominated Advisor)

 

020 3368 3551

Claire Louise Noyce

Hybridan LLP, Broker

020 3764 2341

 

Stephanie Forrest

T/F/D, Public Relations

07917 695755

 

Notes

About Kin Wellness

 

Kin Wellness provides digital wellness solutions that empower employers to create a positive culture of health within their organisation. By helping employees to embrace a healthier way of living, Kin Wellness can help maximise performance, reduce absenteeism, decrease the risk of chronic illness, and lower healthcare costs.

 

The Company's technological edge allows it to address holistic wellness by engaging both individuals and teams through intelligent, personalised interaction and gamification. This is an opportunity to make incremental behavioural changes that will last a lifetime. The progress of individuals translates to actionable data, meaningful reporting and insights that allow the organisation to monitor the impact of the programme and to refine it in order to achieve success.

 

Shares are admitted to trading on the London Stock Exchange AIM market under ticker KIN.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IODOKBDPCBKDOAD
Date   Source Headline
11th Feb 20202:06 pmRNSSecond Price Monitoring Extn
11th Feb 20202:00 pmRNSPrice Monitoring Extension
11th Feb 202011:05 amRNSSecond Price Monitoring Extn
11th Feb 202011:00 amRNSPrice Monitoring Extension
11th Feb 20207:15 amRNSAppointment of Andrew House to Advisory Committee
11th Feb 20207:00 amRNS2019 Year End Trading Update
10th Feb 20202:06 pmRNSSecond Price Monitoring Extn
10th Feb 20202:00 pmRNSPrice Monitoring Extension
3rd Jan 20204:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20204:35 pmRNSPrice Monitoring Extension
23rd Dec 20199:35 amRNSBlock listing Interim Review
20th Dec 20196:06 pmRNSConfirmation regarding Trading Update
19th Dec 20197:00 amRNSMilestone Advertising Trading Agreement
18th Dec 20197:00 amRNSTrading Update
17th Dec 20192:06 pmRNSSecond Price Monitoring Extn
17th Dec 20192:00 pmRNSPrice Monitoring Extension
4th Nov 201910:17 amRNSGrant of Share Options
29th Oct 201911:34 amRNSAppointment of Bryan Neider to Advisory Committee
28th Oct 20193:21 pmRNSExercise of Options and Total Voting Rights
28th Oct 201911:05 amRNSSecond Price Monitoring Extn
28th Oct 201911:00 amRNSPrice Monitoring Extension
28th Oct 201910:25 amRNSDirectors' dealings
30th Sep 20197:00 amRNSInterim results for the six months ended 30 June
27th Sep 20195:24 pmRNSStrategic Partnership with Dentsu Aegis Network
26th Sep 20197:00 amRNSExtension of Football Manager Agreement
17th Sep 201912:13 pmRNSNotice of Results
30th Aug 201911:03 amRNSTotal Voting Rights
29th Aug 20194:01 pmRNSNew contract with The Trade Desk
22nd Aug 20192:35 pmRNSChange of Broker
19th Aug 201911:45 amRNSCollaboration with Epic Games' Unreal Engine
13th Aug 20192:06 pmRNSSecond Price Monitoring Extn
13th Aug 20192:00 pmRNSPrice Monitoring Extension
12th Aug 20195:09 pmRNSBidstack signs contract with AppNexus
1st Aug 20197:00 amRNSAcquisition of Pubguard
31st Jul 20197:00 amRNSTotal Voting Rights
11th Jul 20194:40 pmRNSSecond Price Monitoring Extn
11th Jul 20194:35 pmRNSPrice Monitoring Extension
11th Jul 20192:05 pmRNSSecond Price Monitoring Extn
11th Jul 20192:00 pmRNSPrice Monitoring Extension
2nd Jul 20197:00 amRNSAppointment of Derek Wise and other Board changes
24th Jun 20193:42 pmRNSResults of Independent Study by Lumen Research
11th Jun 20198:09 amRNSBlock Listing Application
11th Jun 20197:00 amRNSExercise of Warrants and Total Voting Rights
7th Jun 20197:00 amRNSIssue of Equity and Total Voting Rights
6th Jun 201910:01 amRNSExercise of Warrants and Total Voting Rights
6th Jun 20197:00 amRNSExercise of Warrants and Total Voting Rights
3rd Jun 20197:00 amRNSExercise of Warrants and Total Voting Rights
31st May 20195:04 pmRNSAppointments to Advisory Board
28th May 20199:05 amRNSSecond Price Monitoring Extn
28th May 20199:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.